249 related articles for article (PubMed ID: 12060623)
21. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
[TBL] [Abstract][Full Text] [Related]
22. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.
Satyamoorthy K; Li G; Vaidya B; Patel D; Herlyn M
Cancer Res; 2001 Oct; 61(19):7318-24. PubMed ID: 11585772
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.
Lee CT; Park KH; Adachi Y; Seol JY; Yoo CG; Kim YW; Han SK; Shim YS; Coffee K; Dikov MM; Carbone DP
Cancer Gene Ther; 2003 Jan; 10(1):57-63. PubMed ID: 12489029
[TBL] [Abstract][Full Text] [Related]
25. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
[TBL] [Abstract][Full Text] [Related]
26. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.
Min Y; Adachi Y; Yamamoto H; Ito H; Itoh F; Lee CT; Nadaf S; Carbone DP; Imai K
Cancer Res; 2003 Oct; 63(19):6432-41. PubMed ID: 14559833
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
Tai YT; Podar K; Catley L; Tseng YH; Akiyama M; Shringarpure R; Burger R; Hideshima T; Chauhan D; Mitsiades N; Richardson P; Munshi NC; Kahn CR; Mitsiades C; Anderson KC
Cancer Res; 2003 Sep; 63(18):5850-8. PubMed ID: 14522909
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-I receptor - a potential therapeutic target in medulloblastomas.
Reiss K
Expert Opin Ther Targets; 2002 Oct; 6(5):539-44. PubMed ID: 12387677
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the biologic response to insulin-like growth factor I in MCF-7 breast cancer cells by a new monoclonal antibody to the insulin-like growth factor-I receptor. The importance of receptor down-regulation.
Jackson-Booth PG; Terry C; Lackey B; Lopaczynska M; Nissley P
Horm Metab Res; 2003; 35(11-12):850-6. PubMed ID: 14710368
[TBL] [Abstract][Full Text] [Related]
30. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
31. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
[TBL] [Abstract][Full Text] [Related]
33. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH
J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
[TBL] [Abstract][Full Text] [Related]
35. Cell lineage-specific signaling of insulin and insulin-like growth factor I in rabbit blastocysts.
Navarrete Santos A; Ramin N; Tonack S; Fischer B
Endocrinology; 2008 Feb; 149(2):515-24. PubMed ID: 17962341
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.
Perrini S; Natalicchio A; Laviola L; Cignarelli A; Melchiorre M; De Stefano F; Caccioppoli C; Leonardini A; Martemucci S; Belsanti G; Miccoli S; Ciampolillo A; Corrado A; Cantatore FP; Giorgino R; Giorgino F
Endocrinology; 2008 Mar; 149(3):1302-13. PubMed ID: 18079194
[TBL] [Abstract][Full Text] [Related]
38. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
[TBL] [Abstract][Full Text] [Related]
39. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.
Dews M; Prisco M; Peruzzi F; Romano G; Morrione A; Baserga R
Endocrinology; 2000 Apr; 141(4):1289-300. PubMed ID: 10746631
[TBL] [Abstract][Full Text] [Related]
40. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
